Project Number 5R01AG055606-03 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for SPRINT MIND 2020 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) k. Vasculature Researcher and Organization Principal Investigator REBOUSSIN, DAVID M Principal Investigator First Name DAVID M Principal Investigator Last Name REBOUSSIN Awardee Organization WAKE FOREST UNIVERSITY HEALTH SCIENCES Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-056: Research Project Grant (Parent R01 Clinical Trial Not Allowed) FY Overall Cost $1,404,351 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
